Last Updated on December 11, 2020 by The Health Master
Bharat Biotech is expected to initiate Phase-1 trials of its intranasal vaccine for C-19 next month, chairman and MD Krishna Ella said on Tuesday.
He said his firm is setting up two more facilities for manufacturing vaccines, including for Covaxin. “I think it will enter into Phase 1 (next month) because it is going to be a single dose vaccine.”
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram..
